Eli Lilly Files 8-K on Debt Instruments

Ticker: LLY · Form: 8-K · Filed: 2025-08-20T00:00:00.000Z

Sentiment: neutral

Topics: debt, financing, disclosure

Related Tickers: LLY

TL;DR

LLY filed an 8-K detailing various debt notes due between 2026 and 2061.

AI Summary

Eli Lilly and Company (LLY) filed an 8-K on August 20, 2025, reporting "Other Events" and "Financial Statements and Exhibits" as of August 18, 2025. The filing details various debt instruments, including notes due in 2026, 2030, 2031, 2033, 2036, 2043, 2049, 2051, and 2061, indicating potential financing activities or debt management. No specific dollar amounts for these notes were provided in the excerpt.

Why It Matters

This filing indicates Eli Lilly is actively managing its debt structure, which could impact its financial leverage and future borrowing costs.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of debt instruments and does not appear to contain significant new risks.

Key Players & Entities

FAQ

What specific types of debt instruments are detailed in the filing?

The filing details various notes with different interest rates and maturity dates, including A1.625% Notes due June 2, 2026, A2.125% Notes due June 3, 2030, A6.25% Notes due 2031, A5.00% Notes due 2033, A6.77% Notes due January 1, 2036, A1.625% Notes due 2043, A1.700% Notes due 2049, A1.125% Notes due 2051, and A1.375% Notes due 2061.

What is the filing date for this 8-K?

The filing date is August 20, 2025.

What is the period of report for this 8-K?

The conformed period of report is August 18, 2025.

What are the main items reported in this 8-K filing?

The main items reported are 'Other Events' and 'Financial Statements and Exhibits'.

What is Eli Lilly's state of incorporation and fiscal year end?

Eli Lilly's state of incorporation is IN, and its fiscal year end is 1231.

From the Filing

0001193125-25-184093.txt : 20250820 0001193125-25-184093.hdr.sgml : 20250820 20250820161608 ACCESSION NUMBER: 0001193125-25-184093 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 23 CONFORMED PERIOD OF REPORT: 20250818 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250820 DATE AS OF CHANGE: 20250820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 251236962 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 8-K 1 d929636d8k.htm 8-K 8-K ELI LILLY & Co false 0000059478 0000059478 2025-08-18 2025-08-18 0000059478 us-gaap:CommonClassAMember 2025-08-18 2025-08-18 0000059478 lly:A1.625NotesDueJune22026Member 2025-08-18 2025-08-18 0000059478 lly:A2.125NotesDueJune32030Member 2025-08-18 2025-08-18 0000059478 lly:A625Notesdue2031Member 2025-08-18 2025-08-18 0000059478 lly:A500NotesDue2033Member 2025-08-18 2025-08-18 0000059478 lly:A6.77NotesDueJanuary12036Member 2025-08-18 2025-08-18 0000059478 lly:A1625NotesDue2043Member 2025-08-18 2025-08-18 0000059478 lly:A1.700Notesdue2049Member 2025-08-18 2025-08-18 0000059478 lly:A1125NotesDue2051Member 2025-08-18 2025-08-18 0000059478 lly:A1375NotesDue2061Member 2025-08-18 2025-08-18     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 18, 2025     ELI LILLY AND COMPANY (Exact Name of Registrant as Specified in its Charter)       Indiana   001-06351   35-0470950 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) Lilly Corporate Center Indianapolis , Indiana     46285 (Address of Principal Executive Offices)     (Zip Code) Registrant’s Telephone Number, Including Area Code: (317) 276-2000 Not Applicable (Former Name or Former Address, if Changed Since Last Report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see  General Instruction A.2.):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock (no par value)   LLY   New York Stock Exchange 1.625% Notes due 2026   LLY26   New York Stock Exchange 2.125% Notes due 2030   LLY30   New York Stock Exchange 0.625% Notes due 2031   LLY31   New York Stock Exchange 0.500% Notes due 2033   LLY33   New York Stock Exchange 6.77% Notes due 2036   LLY36   New York Stock Exchange 1.625% Notes due 2043   LLY43   New York Stock Exchange 1.700% Notes due 2049   LLY49A

View on Read The Filing